¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"linear metabolic pathway"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® basal metabolic rate(BMR) ÇÑ±Û ±âÃÊ´ë»çÀ²
¼³¸í   
  Ç¥ÁØ ±âÃÊ´ë»ç·®°ú ºñ±³ÇßÀ» ¶§ °³Ã¼ ±âÃÊ´ë»ç·®ÀÌ º¸À̴ ÆíÂ÷¸¦ Ç¥½ÃÇϴ Áö¼ö. ±âÃÊ´ë»ç·®Àº »ý¸íÀ» À¯ÁöÇϴµ¥ ÇÊ¿äÇÑ ÃÖ¼ÒÇÑÀÇ ¿¡³ÊÁö ´ë»ç·®À̸ç, ¼º°ú ¿¬·ÉÀÌ µ¿ÀÏÇÑ °Ç°­ÀÎÀÇ ±âÃÊ´ë»ç·®Àº Ã¼Ç¥¸éÀû¿¡ ºñ·ÊÇÑ´Ù. À̰ÍÀ» Ã¼Ç¥¸éÀûÀÇ ¹ýÄ¢À̶ó°í Çϸç, 1882³â µ¶ÀÏÀÇ ´ë»ç»ý¸®ÇÐÀÚ M. ºê·ç³Ê¿¡ ÀÇÇØ Á¦Ã¢µÇ¾ú´Ù. Ã¼Ç¥¸éÀûÀº ½ÅÀå°ú Ã¼Áß¿¡ ÀÇÇØ »êÃâµÈ´Ù. µû¶ó¼­ ¼º-¿¬·É-½ÅÀå-üÁßÀ» ¾Ë¸é Ç¥ÁرâÃÊ·® Y°¡ »êÃâµÇ°í ½ÇÁ¦ÀÇ ±âÃÊ´ë»ç·® X´Â »ê¼Ò¼Òºñ·®°ú ÀÌ»êȭź¼Ò ¹ß»ý·®¿¡¼­ »êÃâµÈ´Ù. ±×¸®°í X¿Í YÀÇ Â÷À̸¦ Y·Î ³ª´« °ª(%)À» ±âÃÊ´ë»çÀ²À̶ó°í ÇÑ´Ù. °æÇèÀûÀ¸·Î ¾òÀº BMRÀÇ °£´ÜÇÑ ÃøÁ¤¹ýµµ ÀÖÀ¸¸ç ´ÙÀ½°ú °°Àº ½ÄÀ¸·Î ±¸ÇÑ´Ù. ÀÌ ½Ä¿¡¼­ ¸ÆÆøÀ̶õ ÃÖ°íÇ÷¾Ð°ú ÃÖÀúÇ÷¾ÐÀÇ Â÷¸¦ ¸»ÇÑ´Ù. BMR(%)=0.75(1ºÐ ¸Æ¹Ú¼ö + 0.74¡¿¸ÆÆø)£­72. BMRÀÌ 10% À̳»À̸é Á¤»ó¹üÀ§, +10% ÀÌ»óÀ̸頱âÃÊ´ë»çÇ×Áø, £­10% ÀÌÇÏÀ̸頱âÃÊ´ë»ç ÀúÇ϶ó°í ÇÑ´Ù. ±âÃÊ´ë»ç´Â °øº¹½Ã(½ÄÈÄ 10½Ã°£ °æ°ú)¿¡ ¾ÈÁ¤µÈ »óÅ¿¡¼­ ´ÜÀ§ ½Ã°£´ç ÀÌ¿ëµÇ´Â ¿¡³ÊÁöÀÇ ¾ç, Áï, ÇÑ ½Ã°£´ç, ¸ö Ç¥¸éÀÇ 1m2´ç ¶Ç´Â ¸ö¹«°Ô 1kg ´ç Ä®·Î¸®·Î ³ªÅ¸³½´Ù. À̰ÍÀº °³Àο¡ µû¶ó ´Ù¸£¸ç Àå±â°£¿¡´Â °ÅÀÇ º¯È­°¡ ¾øÁö¸¸ Áúº´ µîÀ¸·Î ÀÎÇØ º¯µ¿µÈ´Ù. ½ÇÃøÇÑ ±âÃÊ´ë»ç¸¦ Ç¥ÁØÄ¡¿Í ºñ±³ÇÔÀ¸·Î½á Áúº´ÀÇ Áø´Ü µî¿¡ ÀÀ¿ëÇÒ ¼ö ÀÖ´Ù BMR=(½ÇÃøÄ¡-Ç¥ÁØÄ¡)/Ç¥ÁØÄ¡ ¡¿100(%)·Î ³ªÅ¸³½´Ù.
¿µ¹® linear accelerator ÇÑ±Û ¼±»ó°¡¼Ó±â
¼³¸í   
  Ä¡·á¹æ»ç¼±°ú¿¡¼­ ÀÌ¿ëÇϴ ±â°è·Î¼­ ÀüÀÚ¸¦ »ý¼ºÇØ ³½´Ù. ÀüÀڴ ´Ü¼øÈ÷ X-¼±°ú´Â ´Ù¸¥ °ÍÀ¸·Î ÀüÀÚ°¡ ±Ý¼Ó¿¡ ºÎµúÇô ³ª¿À´Â °ÍÀÌ X-¼±ÀÌ´Ù. ÀüÀڴ Áø´Ü¸ñÀûº¸´Ù´Â Ä¡·á¸ñÀûÀ¸·Î ÁַΠÇǺÎÀÇ ¾Ç¼ºÁ¾¾ç(¾Ï)¿¡ »ç¿ëµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • metabolic pathway
    ´ë»ç°æ·Î
  • accessory pathway
    µ¡Àüµµ·Î, ºÎÀüµµ·Î
  • alternative complement pathway
    ´ëüº¸Ã¼°æ·Î
  • biosynthetic pathway
    »ýÇÕ¼º°æ·Î
  • classic complement pathway
    ÀüÇüÀûº¸Ã¼°æ·Î
  • coagulation pathway
    ÀÀ°í°æ·Î
  • extrinsic pathway of coagulation
    ¿ÜÀμºÀÀ°í°æ·Î
  • intrinsic pathway of coagulation
    ³»ÀμºÀÀ°í°æ·Î
  • interneuronal signaling pathway
    ½Å°æ¼¼Æ÷°£½ÅÈ£Àü´Þ°æ·Î
  • internodal pathway
    °áÀý°£°æ·Î
  • motor pathway
    ¿îµ¿½Å°æ·Î
  • pain pathway
    ÅëÁõÀü´Þ·Î
  • pathway
    °æ·Î, Åë·Î
  • subthalamopallidal pathway
    ½Ã»ó¹ØÃ¢¹éÇÙ·Î
  • sensory pathway
    °¨°¢·Î
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • metabolic pathway
    ´ë»ç°æ·Î
  • linear acceleration
    ¼±Çü°¡¼Ó
  • linear fracture
    ¼±°ñÀý
  • linear regression
    ¼±Çüȸ±Í
  • pathway
    °æ·Î, Åë·Î
  • accessory pathway
    µ¡Àüµµ·Î, ºÎÀüµµ·Î
  • biosynthetic pathway
    »ýÇÕ¼º°æ·Î, »ýÇÕ¼º°úÁ¤
  • sensory pathway
    °¨°¢·Î
  • visual pathway
    ½Ã°¢°æ·Î
  • metabolic acidosis
    ´ë»ç»êÁõ
  • metabolic disease
    ´ë»çº´, ´ë»çÁúȯ
  • metabolic disorder
    ´ë»çÀå¾Ö
  • metabolic
    ´ë»ç-
  • basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • metabolic turnover
    ´ë»çÀüȯ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • metabolic pathway
    ´ë»ç°æ·Î
  • accessory pathway
    ºÎÀüµµ·Î
  • alternative complement pathway
    º¸Ã¼´ëü°æ·Î, µµ¿òü´ëü°æ·Î
  • biosynthetic pathway
    »ýÇÕ¼º°æ·Î, »ýÇÕ¼º°úÁ¤
  • classic complement pathway
    º¸Ã¼ÀüÇüÀû°æ·Î, µµ¿òüÀüÇüÀû°æ·Î
  • coagulation pathway
    ÀÀ°í°æ·Î
  • interneuronal signaling pathway
    ½Å°æ¼¼Æ÷°£½ÅÈ£Àü´Þ°æ·Î
  • internodal pathway
    ¸¶µð»çÀ̱æ
  • motor pathway
    ¿îµ¿½Å°æ·Î
  • pathway
    °æ·Î, Åë·Î
  • pain pathway
    ÅëÁõÀü´Þ·Î
  • sensory pathway
    °¨°¢·Î
  • subthalamopallidal pathway
    ½Ã»ó¹ØÃ¢¹éÇÙ·Î, ½Ã»óÇÏ´ãⱸ·Î
  • transcellular pathway
    ¼¼Æ÷Ⱦ´Ü°æ·Î
  • visual pathway
    ½Ã°¢°æ·Î
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • BMR=£¾basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • porphyrin metabolic disorder
    Æ÷¸£ÇǸ°´ë»çÀå¾Ö
  • relative metabolic rate
    »ó´ëÀû ´ë»çÀ².
  • Linear acceleration
    ¼±»ó°¡¼Ó(àÊ߾ʥáÜ)
  • arrays, linear sequenced
    ¼±Çü ¼øÂ÷ ¹è¿­ (àÊû¡ â÷ó­ ÛÉæê)
  • high linear energy transfer radiation
    °í¼±Çü¿¡³ÊÁöÀüÀ̹æ»ç¼±
  • phased linear array type
    À§»óÂ÷ ¼±Çü ¹è¿­½Ä
  • phased linear array type
    À§»óÂ÷ ¹è¿­½Ä ¼±Çü (êÈßÓó¬ ÛÕÖªãÒ àÊû¡) Æ®·£½ºµà¼­
  • radiation,linear energy transfer (let)
    ¼±»ó¿¡³ÊÁöÀüȯ(àÊß¾¡­ï®üµ)
  • Embden-Meyerhof pathway
    ¿¥µ§-¸¶À̾î·ÎÇÁ °æ·Î(ÌèÖØ)
  • Lemniscus pathway
    ¸ð´ë°æ·Î(Ù¶ÓáÌèÖØ)
  • accessory pathway
    ºÎÀüµµ·Î.
  • acetate pathway
    ¾Æ¼¼Å×ÀÌÆ® ´ë»ç°æ·Î(¡­ÓÛÞóÌèÖØ).
  • acoustic pathway
    û°¢·Î
  • alternative pathway
    ±³´ë°æ·Î
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • metabolic pathway
    ´ë»ç°æ·Î.
  • accessory pathway
    ºÎÀüµµ·Î.
  • acetate pathway
    ¾Æ¼¼Å×ÀÌÆ® ´ë»ç°æ·Î(¡­ÓÛÞóÌèÖØ).
  • acoustic pathway
    û°¢·Î
  • alternative pathway
    ±³´ë°æ·Î
  • alternative pathway
    º°µµ°æ·Î, ´ëü°æ·Î
  • biosynthetic pathway
    »ýÇÕ¼º°úÁ¤<°æ·Î>(¡­<ÌèÖØ>).
  • biosynthetic pathway
    »ýÇÕ¼º°æ·Î(¡­ÌèÖØ).
  • classic pathway
    ÀüÇüÀû °æ·Î
  • classical pathway
    °íÀü°æ·Î, °íÀüÀû°æ·Î (º¸Ã¼¹ÝÀÀÀÇ)
  • coagulation,intrinsic pathway
    ³»ºÎ °æ·Î(ҮݻÌèÖØ)
  • complement system, alternative pathway
    ´ëü°æ·Î(ÓÛôðÌèÖØ)
  • complement system, classic pathway
    ÀüÇüÀû °æ·Î(îðúþîÜÌèÖØ)
  • corticastriatal pathway
    ÇÇÁú¼±Á¶Ã¼°æ·Î(ù«òõàÊðÉô÷ÌèÖØ)
  • cyclooxygenase pathway
    »çÀÌŬ·Î¿Á½Ã°Ô³ªÁ¦ ȸ·Î(¡­üÞÖØ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Metabolic defect of minerals (Asiderosis)
    ¹«±âÁú´ë»ç°áÇÔ(ö°¨¼ÒÁõ)
    [¿¾ ¿ë¾î] ¹«±âÁú´ë»ç°áÇÔ(ö°¨¼ÒÁõ)
  • Metabolic defect of pigment (Methemoglobinemia)
    »ö¼Ò´ë»ç°áÇÔ(¸ÞÆ®Çì¸ð±×·ÎºóÇ÷Áõ)
    [¿¾ ¿ë¾î] »ö¼Ò´ë»ç°áÇÔ(¸ÞÆ®Çì¸ð±×·ÎºóÇ÷Áõ)
  • Congenital metabolic defect
    ¼±Ãµ´ë»ç°áÇÔ
    [¿¾ ¿ë¾î] ¼±Ãµ¼º´ë»ç¼º°áÇÔ
  • Metabolic defect of steroid (Adrenogenital syndrome)
    ½ºÅ×·ÎÀ̵å´ë»ç°áÇÔ(ºÎ½Å»ý½Ä±âÁõÈıº)
    [¿¾ ¿ë¾î] ½ºÅ×·ÎÀ̵å´ë»ç°áÇÔ(ºÎ½Å»ý½Ä±âÁõÈıº)
  • Metabolic defect of amino acid (Alkaptonuria)
    ¾Æ¹Ì³ë»ê´ë»ç°áÇÔ(¾Ëİſ´¢Áõ)
    [¿¾ ¿ë¾î] ¾Æ¹Ì³ë»ê´ë»ç°áÇÔ(¾Ëİſ´¢Áõ)
  • Metabolic defect of carbohydrate (Galactosemia)
    ź¼öÈ­¹°´ë»ç°áÇÔ(°¥¶ôÅä¿À½ºÇ÷Áõ)
    [¿¾ ¿ë¾î] ź¼öÈ­¹°´ë»ç°áÇÔ(°¥¶ôÅä¿À½ºÇ÷Áõ)
  • Metabolic defect of nucleic acid (Purinemia)
    ÇÙ»ê´ë»ç°áÇÔ(Ç»¸°Ç÷Áõ)
    [¿¾ ¿ë¾î] ÇÙ»ê´ë»ç°áÇÔ(Ç»¸°Ç÷Áõ)
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • metabolic antigen
    ´ë»çÇ׿ø
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • linear metabolic pathway
    ¼±Çü ´ë»ç°æ·Î(àÊû¡ÓÛÞóÌèÖØ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • branched metabolic pathway
    ºÐÁö´ë»ç°æ·Î(ÝÂò«ÓÛÞóÌèÖØ)
  • central metabolic pathway
    ÁßÃß´ë»ç°æ·Î(ñéõÒÓÛÞóÌèÖØ)
  • cyclic metabolic pathway
    ȸ·Î ´ë»ç°æ·Î(üÞÖØÓÛÞóÌèÖØ)
  • layered metabolic pathway
    Ãþ´ë»ç°æ·Î(öµÓÛÞóÌèÖØ)
  • metabolic pathway
    ´ë»ç °æ·Î(ÓÛÞóÌèÖØ)
  • reversible metabolic pathway
    °¡¿ª ´ë»ç°æ·Î(ÓÛÞóÌèÖØ)
  • tiered metabolic pathway
    ÃþÃþ´ë»ç °æ·Î (öµöµÓÛÞóÌèÖØ)
  • linear absorption coefficient
    ¼±Èí¼ö°è¼ö(àÊýåâ¥Ìõâ¦)
  • linear accelerator
    ¼±Çü°¡¼Ó±â(àÊû¡Ê¥áÜѦ)
  • linear chain
    ¼±Çü(àÊû¡)»ç½½
  • linear correlation
    ¼±Çü »ó°ü(àÊû¡ßÓμ)
  • linear density gradient
    ¼± ¹Ðµµ(à»ÚËÓø)±â¿ï±â
  • linear dichroism
    ¼±Çü ÀÌ»ö¼º(àÊû¡ì£ßäàõ)
  • linear electric field effect
    ¼±Çü Àü±âÀåÈ¿°ú(àÊû¡ï³Ñ¨íÞüùÍý)
  • linear energy transfer
    ¼±Çü(àÊû¡) ¿¡³ÊÁöÀüÀÌ(ï®ì¹)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • optic pathway
    ½Ã½Å°æ·Î
  • pathway
    °æ·Î
  • basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • metabolic
    ´ë»ç¼ºÀÇ
  • metabolic acidosis
    ´ë»ç¼º»êÁõ, ´ë»ç¼º¾Æ½Ãµµ½Ã½º
  • metabolic alkalosis
    ´ë»ç¼º¾ËÄ®¸®Áõ
  • metabolic disease
    ´ë»ç¼ºÁúȯ
  • metabolic disorder
    ´ë»çÀå¾Ö
  • metabolic rate
    ´ë»çÀ²
  • digital linear tape(DLT)
    µðÁöÅÐ Å×ÀÌÇÁ ÀúÀåÀåÄ¡
  • fine horizontal linear opacity
    ¹Ì¼¼ÇÑ ¼öÆò¸éÇü ¼±»ó ºÒÅõ¸íü
  • general linear model
    ÀϹÝÀû ¼±Çü¸ðµ¨, ÀÏ¹Ý ¼±»ó¸ðµ¨
  • linear
    ¼±»ó, ¼±Çü
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • linear array
    ¼±Çü ¹è¿­
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
EM Pathway Embden Meyerhof Pathway
AP accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p...
ACP accessory conduction pathway; acid phosphatase; acyl carrier protein; American College of Pathologis...
AERPAP antegrade effective refractory period accessory pathway
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AP accessory pathway
ACP Alternative complement pathway
AP Alternative pathway
CP Classical pathway
EPI Extrinsic Pathway Inhibitor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • metabolic pathway
    ´ë»ç °æ·Î
  • coefficient of linear thermal expansion
    ¿­ ÆØÃ¢ °è¼ö
    ¹°Ã¼ÀÇ ¿Âµµ¸¦ 1µµ »ó½Â½ÃÅ´¿¡ µû¸¥ ±æÀÌÀÇ Áõ°¡À².
  • fine horizontal linear opacity
    ¹Ì¼¼ÇÑ ¼öÆò¸éÇü ¼±»ó ºÒÅõ¸íü
  • linear
    ¼±»ó, ¼±Çü, ¼±»óÀÇ
    ¼±¿¡ ¼ÓÇϰųª ¼±°ú ´àÀº.
  • linear coefficient of expansion
    ¼± ÆØÃ¢ °è¼ö
    °íüÀÇ ¿­ ÆØÃ¢¿¡ µû¸¥ ±æÀÌÀÇ º¯È­ ºñÀ². 0 ¡É¿¡¼­ ±æÀÌ lÀÎ ¹°Ã¼°¡ ¿Âµµ º¯È­ d¿¡ ´ëÇØ dl¸¸Å­ ¿­ ÆØÃ¢ÇÒ ¶§,
  • linear coefficient of thermal expansion
    ¼± ¿­ ÆØÃ¢ °è¼ö
  • linear energy transfer
    ¼± ¿¡³ÊÁö ºÎ¿©
  • linear expansion
    ¼± ÆØÃ¢
    ¹°Ã¼ÀÇ ±æÀ̰¡ ´Ã¾î³ª´Â °Í. ƯÈ÷ ¹°Ã¼°¡ ÀÏÁ¤ ¾Ð·ÂÇÏ¿¡¼­ ¿ÂµµÀÇ º¯È­¿¡ µû¶ó Å©±â¸¦ º¯È­½ÃŰ´Â °ÍÀ» ¿­ ÆØÃ¢À̶ó°í ÇÑ´Ù.
  • linear IgA disease
    ¼±»ó ¸é¿ª ±Û·ÎºÒ¸° A Áúȯ
  • linear lichen planus
    ¼±»ó ÆíÆò ż±
  • linear nevus sebaceous syndrome
    ¼±»ó ¸ð¹Ý ÇÇÁö¼± ÁõÈıº
  • linear optical characteristics
    ¼±Çü ±¤ÇРƯ¼º
  • linear polymer
    ¼±»ó ÁßÇÕü
    ºÐÀÚÀÇ Çü»óÀÌ »ç»óÀÎ ÁßÇÕ¹°·Î ºÐÁöÇÑ ÁßÇÕ¹°, ȤÀº °¡°øµÈ ÁßÇÕ¹°¿¡ ´ëºñµÈ´Ù´Â ¶æ.
  • linear shadow
    ¼±»ó À½¿µ
  • linear tomography
    ¼±Çü ´ÜÃþ ÃÔ¿µ¼ú, ¼±Çü ´ÜÃþ ÃÔ¿µ¼ú¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
programming, linear A technique of operations research for solving certain kinds of problems involving many variables where a best value or set of best values is to be found. It is most likely to be feasible when the quantity to be optimised, sometimes called the objective function, can be stated as a mathematical expression in terms of the various activities within the system, and when this expression is simply proportional to the measure of the activities, i.e., is linear, and when all the restrictions are also linear. It is different from computer programming, although problems using linear programming techniques may be programmed on a computer.
(12 Dec 1998)
non-linear Not linear.
(05 Dec 1998)
superficial linear keratitis Spontaneous, painful keratitis with epithelial erosion and folds in Bowman's membrane.
(05 Mar 2000)
linear Pertaining to or resembling a line.
Origin: L. Linearis
(18 Nov 1997)
linear absorption coefficient That fraction of ionizing radiation absorbed in a unit thickness of a substance or tissue.
See: absorption coefficient.
(05 Mar 2000)
linear acceleration The rate of change of velocity without a change in direction; e.g., when the speed of an aircraft increases while flying a straight pathway.
(05 Mar 2000)
linear accelerator <apparatus> A sophisticated external beam radiotherapy machine which has the capabilities of focussing irradiation (although not very finely).
Acronym: LinAC
(16 Dec 1997)
linear amputation Amputation performed by a circular incision through the skin, the muscles being similarly divided higher up, and the bone higher still.
Synonym: guillotine amputation, linear amputation.
(05 Mar 2000)
linear atrophy Bands of thin wrinkled skin, initially red but becoming purple and white, which occur commonly on the abdomen, buttocks, and thighs at puberty and/or during and following pregnancy, and result from atrophy of the dermis and overextension of the skin; also associated with ascites and Cushing's syndrome.
Synonym: atrophoderma striatum, lineae albicantes, lineae atrophicae, linear atrophy, stretch marks, stria, striae atrophicae, striate atrophy of skin, traction atrophy, vergeture.
(05 Mar 2000)
linear dichroism <chemistry> Differential absorption of right hand and left hand circularly polarized light resulting from molecular asymmetry involving a chromophore group. Circular dichroism is used to study the conformation of proteins in solution.
(18 Nov 1997)
linear energy transfer <radiobiology> Average amount of energy lost per unit of particle track length and expressed in keV um-1.
Acronym: LET
(16 Dec 1997)
linear epidermal nevus A congenital systematised linear nevus limited to one side of the body or to portions of the extremities on one side; lesions are often extensive, forming wave-like bands on the trunk and spiraling streaks on the extremities.
Synonym: linear epidermal nevus.
(05 Mar 2000)
linear fracture A fracture running parallel with the long axis of the bone.
Synonym: fissured fracture.
(05 Mar 2000)
linear IgA bullous disease in children A rare self-limiting bullous disease, chiefly of the trunk, perioral, and pelvic areas, with onset in the first decade, successively less severe recurrences, and total remission at adolescence; linear epidermal basement membrane zone deposit of IgA is found in involved and in normal skin.
Synonym: linear IgA bullous disease in children.
(05 Mar 2000)
linear models Statistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • metabolic
    (½ÅÁø)´ë»çÀÇ
  • pathway
    Á¼Àº±æ;¿À¼Ö±æ
  • linear
    ÁÙÀÇ
  • linear
    Á÷¼±ÀÇ(À¸·Î ÀÌ·ç¾îÁø);¼±ÀÇ
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • linear measure
    ôµµ
  • linear motor
    ¼±Çü¸ðÅÍ
  • linear programming
    ¼±Çü°èȹ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á